Literature DB >> 19211818

Fasting and postprandial markers of inflammation in lean and overweight children.

Jessica A Alvarez1, Paul B Higgins, Robert A Oster, José R Fernandez, Betty E Darnell, Barbara A Gower.   

Abstract

BACKGROUND: Overweight children have greater circulating concentrations of markers of inflammation (MOI) than do lean children. Whether adiposity influences the postprandial MOI response is unknown.
OBJECTIVE: We aimed to evaluate the relations of fasting and postprandial MOI with total and regional adiposity and insulin sensitivity in children.
DESIGN: Fifty-nine children aged 7-12 y were assessed for C-reactive protein (CRP), interleukin-6 (IL-6), and soluble tumor necrosis factor receptor-2 (sTNF-R2) in the fasted state and after a mixed meal. Insulin sensitivity, body composition, and abdominal adipose tissue distribution were assessed with a frequently sampled intravenous-glucose-tolerance test, dual-energy X-ray absorptiometry, and computed tomography, respectively.
RESULTS: Central adipose measures were not independently associated with fasting MOI, although they were independently inversely associated with the postprandial sTNF-R2 response (r = -0.30 to -0.37, P = 0.02-0.006). The inverse association between intraabdominal adipose tissue and the postprandial CRP response was nearly significant (r = -0.27, P = 0.05). Insulin sensitivity was not associated with fasting or postprandial CRP or sTNF-R2; however, there was a positive relation between insulin sensitivity and fasting IL-6 (r = 0.27, P = 0.03), which was attenuated after adjustment for lean body mass (r = 0.25, P = 0.08).
CONCLUSIONS: Excess adiposity is associated with both fasting and postprandial MOI. The postprandial MOI response may be influenced by central adiposity in children. The positive association of insulin sensitivity with IL-6 warrants further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211818      PMCID: PMC2667459          DOI: 10.3945/ajcn.2008.26926

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  48 in total

1.  C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors.

Authors:  D G Cook; M A Mendall; P H Whincup; I M Carey; L Ballam; J E Morris; G J Miller; D P Strachan
Journal:  Atherosclerosis       Date:  2000-03       Impact factor: 5.162

2.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

Authors:  H K Meier-Ewert; P M Ridker; N Rifai; N Price; D F Dinges; J M Mullington
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

3.  Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.

Authors:  C Tsigos; I Kyrou; E Chala; P Tsapogas; J C Stavridis; S A Raptis; N Katsilambros
Journal:  Metabolism       Date:  1999-10       Impact factor: 8.694

4.  Low-grade systemic inflammation in overweight children.

Authors:  M Visser; L M Bouter; G M McQuillan; M H Wener; T B Harris
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

5.  Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children.

Authors:  Barbara A Gower; Wesley M Granger; Frank Franklin; Richard M Shewchuk; Michael I Goran
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.

Authors:  Francesco Nappo; Katherine Esposito; Michele Cioffi; Giovanni Giugliano; Anna Maria Molinari; Giuseppe Paolisso; Raffaele Marfella; Dario Giugliano
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

7.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

8.  Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect.

Authors:  Ahmad Aljada; Priya Mohanty; Husam Ghanim; Toufic Abdo; Devjit Tripathy; Ajay Chaudhuri; Paresh Dandona
Journal:  Am J Clin Nutr       Date:  2004-04       Impact factor: 7.045

9.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

10.  Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity.

Authors:  Paule Barbeau; Mark S Litaker; Kristy F Woods; Christian R Lemmon; Matthew C Humphries; Scott Owens; Bernard Gutin
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

View more
  13 in total

1.  High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents.

Authors:  A Morandi; E Fornari; F Opri; M Corradi; M Tommasi; R Bonadonna; C Maffeis
Journal:  Int J Obes (Lond)       Date:  2017-02-20       Impact factor: 5.095

2.  Does fat fuel the fire: independent and interactive effects of genetic, physiological, and environmental factors on variations in fat deposition and distribution across populations.

Authors:  Lynae J Hanks; Krista Casazza; Jessica A Alvarez; Jose R Fernandez
Journal:  J Pediatr Endocrinol Metab       Date:  2010-12       Impact factor: 1.634

Review 3.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

4.  Use of a simple liquid meal test to evaluate insulin sensitivity and beta-cell function in children.

Authors:  P C Chandler-Laney; P B Higgins; W Granger; J Alvarez; K Casazza; J R Fernandez; C Dalla Man; C Cobelli; B A Gower
Journal:  Pediatr Obes       Date:  2013-02-28       Impact factor: 4.000

5.  The effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial.

Authors:  Rimke C Vos; Jan M Wit; Hanno Pijl; Carolien C Kruyff; Euphemia C A M Houdijk
Journal:  Trials       Date:  2011-05-06       Impact factor: 2.279

6.  A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.

Authors:  Shuiming Xiao; Na Fei; Xiaoyan Pang; Jian Shen; Linghua Wang; Baorang Zhang; Menghui Zhang; Xiaojun Zhang; Chenhong Zhang; Min Li; Lifeng Sun; Zhengsheng Xue; Jingjing Wang; Jie Feng; Feiyan Yan; Naisi Zhao; Jiaqi Liu; Wenmin Long; Liping Zhao
Journal:  FEMS Microbiol Ecol       Date:  2013-10-21       Impact factor: 4.194

7.  Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity.

Authors:  Ehsan Parvaresh Rizi; Sonia Baig; Muhammad Shabeer; Yvonne Teo; Shao Feng Mok; Tze Ping Loh; Faidon Magkos; Sam Virtue; Antonio Vidal-Puig; E Shyong Tai; Chin Meng Khoo; Sue-Anne Toh
Journal:  Nutr J       Date:  2016-12-01       Impact factor: 3.271

8.  Glycemic and Metabolic Effects of Two Long Bouts of Moderate-Intensity Exercise in Men with Normal Glucose Tolerance or Type 2 Diabetes.

Authors:  Saeed Reza Eshghi; Kevin Fletcher; Étienne Myette-Côté; Cody Durrer; Raniah Q Gabr; Jonathan P Little; Peter Senior; Craig Steinback; Margie H Davenport; Gordon J Bell; Dion R Brocks; Normand G Boulé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-11       Impact factor: 5.555

9.  Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: a randomized controlled trial.

Authors:  R C Vos; J M Wit; H Pijl; E C A M Houdijk
Journal:  Nutr Diabetes       Date:  2011-10-03       Impact factor: 5.097

Review 10.  Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.

Authors:  Shuiming Xiao; Liping Zhao
Journal:  FEMS Microbiol Ecol       Date:  2013-12-12       Impact factor: 4.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.